Rathbones Group PLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 188 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rathbones Group PLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$395,000
+12.5%
40,784
-4.0%
0.00%0.0%
Q1 2021$351,000
+21.0%
42,4840.0%0.00%0.0%
Q4 2020$290,000
-38.8%
42,4840.0%0.00%
-50.0%
Q3 2020$474,000
+65.7%
42,484
-6.6%
0.01%
+33.3%
Q2 2020$286,000
+232.6%
45,484
-2.8%
0.01%
+100.0%
Q1 2020$86,000
-58.9%
46,784
-24.3%
0.00%
-50.0%
Q4 2019$209,000
+58.3%
61,7840.0%0.01%
+50.0%
Q3 2019$132,00061,7840.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders